FERMENTA BIOTECH
|
|
BOM : 506414     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Mar 28,2023 |
Price(EOD): ₹ 113.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 332.66 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
FERMENTA BIOTECH | -13.3% | -16.4% | -43.7% |
SUN PHARMACEUTICAL INDUSTRIES | 1.3% | 1.4% | 9.1% |
DIVIS LABORATORIES | 0.6% | -3.8% | -36.5% |
CIPLA | 3% | -7.7% | -12.2% |
DR REDDYS LABORATORIES | 1.2% | 0.6% | 2.9% |
TORRENT PHARMACEUTICALS | 1.6% | 4% | 11.9% |
ABBOTT INDIA | 0.6% | 6.9% | 33.6% |
ZYDUS LIFESCIENCES | 1.2% | 3.8% | 34.4% |
ALKEM LABORATORIES | 0.9% | -1.5% | -10.7% |
FUNDAMENTAL ANALYSIS OF FERMENTA BIOTECH
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF FERMENTA BIOTECH
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
-8.14
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -40.91 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] 0.93
P/B Calculated based on Book Value of Rs 357.44 Cr
[Latest Year - Mar2022 - Consolidated Results ] 0.98
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 340.94 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-8% -52% -51% |
SHARE PRICE MOMENTUM OF FERMENTA BIOTECH
FERMENTA BIOTECH vs SENSEX
DEBT OF FERMENTA BIOTECH
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.62 0.64 0.72 0.66 |
0.66 0.66 0.73 0.68 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF FERMENTA BIOTECH
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF FERMENTA BIOTECH
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-44.03% -396.02% -414.02% -346.97% |
-40.92% -545.11% -449.34% -351.15% |
QtrlyTrend |
-8 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
FERMENTA BIOTECH related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 1% | -1.3% | -11.5% |
S&P BSE ALLCAP | -1.5% | -3.2% | -3.4% |
S&P BSE MIDSMALLCAP | -2.8% | -4.3% | -4.1% |
S&P BSE SMALL CAP | -3.2% | -5.3% | -6.2% |
You may also like the below Video Courses
FAQ about FERMENTA BIOTECH
Is FERMENTA BIOTECH good for long term investment?
As on Mar 28,2023, the Fundamentals of FERMENTA BIOTECH look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of FERMENTA BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is FERMENTA BIOTECH UnderValued or OverValued?
As on Mar 28,2023, FERMENTA BIOTECH is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of FERMENTA BIOTECH ?
As on Mar 28,2023, the Intrinsic Value of FERMENTA BIOTECH is Rs. 232.38 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 122.83
Fair Value [Median EV / Sales Model] : Rs. 234.63
Fair Value [Median Price / Sales Model] : Rs. 232.38
Estimated Median Fair Value of FERMENTA BIOTECH : Rs. 232.38
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is FERMENTA BIOTECH trading at a Premium or Discount?
As on Mar 28,2023, FERMENTA BIOTECH is trading at a Discount of -51% based on the estimates of Median Intrinsic Value!